Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • THE USE OF HPLC AS A TOOL FOR NEONATAL CORD BLOOD SCREENING OF HAEMOGLOBINOPATHY - A VALIDATION STUDY

    A. Al-Madhani, Anil Pathare, Salam Alkindi
    e2019005
    2019-01-01
    https://doi.org/10.4084/mjhid.2019.005
    2055
    PDF: 1209
    HTML: 375
  • Clinical Manifestation of Children with Kawasaki Disease during the COVID-19 Pandemic in Iran: A Case Series

    zahra Fotokian
    e2025017
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.017
    864
    PDF: 817
    HTML: 70
  • APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE

    Alberto L. García-Basteiro, Quique Bassat, Pedro L. Alonso
    e2012015
    2012-03-10
    https://doi.org/10.4084/mjhid.2012.015
    2609
    PDF: 987
    HTML: 15122
  • PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations

    Michele Bibas
    e2024007
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.007
    3611
    PDF: 2532
    HTML: 1508
  • WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 2- FOCUS ON THERAPY

    Michele Bibas, Shayna Sarosiek , Jorge Castillo
    e2025015
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.015
    2603
    PDF: 2045
    HTML: 236
  • ELEVATED SERUM PENTRAXIN-3 LEVELS IS POSITIVELY CORRELATED TO DISEASE SEVERITY AND COAGULOPATHY IN COVID-19 PATIENTS

    Ming Tong, Fang Chen, Xiaolin Xiao, Lianhong Zou, Yu Jiang, Changping Hu, Qing Zheng, Hong Xu, Chen Zhu, Ying Xiong, Yimin Zhu
    e2021015
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.015
    1552
    PDF: 561
    HTML: 282
  • USP9X INCREASED TUMOR ANGIOGENESIS IN MANTLE CELL LYMPHOMA BY UPREGULATION OF CCND1- MEDIATED SOX11

    Gang Huang, Jianjun Liao, Mingli Wang, Yali Huang, Mingjie Tang, Yanyan Hao
    e2022048
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.048
    887
    PDF: 717
    HTML: 216
  • IRON METABOLISM IN THALASSEMIA AND SICKLE CELL DISEASE

    Raffaella Mariani, Paola Trombini, Matteo Pozzi, Alberto Piperno
    e2009006
    2009-10-27
    1657
    PDF: 653
    HTML: 43927
  • Prevention of Early Death in Very Elderly Acute Promyelocytic Leukemia Patients Using Lower Induction Doses of All-trans Retinoic Acid

    Mark Dalgetty, Sruthi Dontu, Chandini Kannan, Amany Keruakous, Locke Bryan, Vamsi Kota, Anand Jillella
    e2025066
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.066
    950
    PDF: 645
    Html: 141
  • ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING

    Masafumi Taniwaki, Mihoko Yoshida, Yosuke Matsumoto, Kazuho Shimura, Junya Kuroda, Hiroto Kaneko
    e2018014
    2018-02-15
    https://doi.org/10.4084/mjhid.2018.014
    5303
    PDF: 1959
    HTML: 1381
  • UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)

    José Luis Piñana, Estela Giménez, Lourdes Vázquez, María Ángeles Marcos, Manuel Guerreiro, Rafael Duarte, Ariadna Pérez, Carlos de Miguel, Ildefonso Espigado, Marta González-Vicent, María Suarez-Lledó, Irene García-Cadenas, Rodrigo Martino, Angel Cedillo, Monserrat Rovira, Rafael de la Cámara, David Navarro, Carlos Solano
    e2024065
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.065
    4050
    Suppl. Files: 1159
    PDF: 1096
    Html: 185
  • NATION-WIDE SURVEY ON THE USE OF THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RA) FOR THE MANAGEMENT OF IMMUNE THROMBOCYTOPENIA IN CURRENT CLINICAL PRACTICE IN ITALY

    Francesco Rodeghiero, Dr. Mariasanta Napolitano, Nicola Vianelli, Lisanna Ghiotto, Silvia Cantoni, Giuseppe Carli, Monica Carpenedo, Valentina Carrai, Ugo Consoli, Gaetano Giuffrida, Elisa Lucchini, Elena Rossi, Cristina Santoro
    e2023019
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.019
    2088
    PDF: 1245
    PDF Appendix: 744
    HTML: 450
  • ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES. Hematopoietic stem cell transplatation in the elderly fo Acute Myeloid Leukemia

    Gabriele Magliano, Andrea Bacigalupo
    e2020081
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.081
    1652
    PDF: 522
    HTML: 166
  • ON THE VERSATILITY OF VON WILLEBRAND FACTOR

    Antoine Rauch, Peter Lenting
    e2013046
    2013-07-10
    https://doi.org/10.4084/mjhid.2013.046
    2862
    PDF: 1151
    HTML: 11227
  • ASSESSMENT OF OBESITY AND HEPATIC LATE ADVERSE EFFECTS IN THE EGYPTIAN SURVIVORS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA: SINGLE CENTER STUDY

    Farida El-Rashedy, Mahmoud Ahmed El-Hawy, Sally El Hefnawy, Mona Mohammed
    e2017026
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.026
    2539
    PDF: 927
    HTML: 1305
    Untitled: 233
  • THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

    Xenofon Papanikolaou, Bart Barlogie, Saad Usmani
    e2011047
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.047
    2508
    PDF: 799
    HTML: 1741
  • ACQUIRED HYPOGONADOTROPIC HYPOGONADISM (AHH) IN THALASSAEMIA MAJOR PATIENTS: AN UNDERDIAGNOSED CONDITION?

    Vincenzo De Sanctis
    e2016001
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.001
    5212
    PDF: 1317
    HTML: 3591
  • HYDROXYCARBAMINE: FROM AN OLD DRUG USED IN MALIGNANT HEMOPATHIES TO A CURRENT STANDARD IN SICKLE CELL DISEASE

    Giovanna Cannas, Solene Poutrel, Xavier Thomas
    e2017015
    2017-02-15
    https://doi.org/10.4084/mjhid.2017.015
    3987
    PDF: 1190
    HTML: 1659
  • CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY

    Maria Ilaria Del Principe, Luca Maurillo, Francesco Buccisano, Giuseppe Sconocchia, Mariagiovanna Cefalo, Giovanna De Santis, Ambra Di Veroli, Concetta Ditto, Daniela Nasso, Massimiliano Postorino, Marco Refrigeri, Cristina Attrotto, Giovanni Del Poeta, Sergio Amadori, Adriano Venditti
    e2014075
    2014-11-01
    https://doi.org/10.4084/mjhid.2014.075
    4196
    PDF: 1960
    HTML: 5340
    Table 1: 212
  • IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination

    Giuseppe Auteri, Simona Paglia, Camilla Mazzoni, Mattia Biondo, Marta Venturi, Andre Davide Romagnoli, Daniela Bartoletti, Michele Cavo, Nicola Vianelli, Francesca Palandri
    e2023029
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.029
    1498
    PDF: 894
    HTML: 322
  • Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)

    Eugenio Galli, Silvia Bellesi, Marcello Viscovo, Federica Sorà, Stefan Hohaus, Nicola Piccirillo, Luca Laurenti, Patrizia Chiusolo, Valerio De Stefano, Simona Sica, Gina Zini
    e2021066
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.066
    1339
    PDF: 548
    HTML: 231
  • EARLY APPLICATION OF HIGH CUT-OFF HAEMODYALISIS FOR DE-NOVO MYELOMA NEPHROPATHY IS ASSOCIATED WITH LONG-TERM DIALYSIS-INDEPENDENCY AND RENAL RECOVERY

    Alhossain A. Khalafallah, Sie Wuong Loi, Sarah Love, Muhajir B. Mohamed, Rose Mace, Ramy Khalil, Miriam Girgs, Rajesh Raj, Mathew Mathew
    e2013007
    2013-01-02
    https://doi.org/10.4084/mjhid.2013.007
    1386
    PDF: 668
    HTML: 2509
    cover letter: 200
  • MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS

    Elena Maino, Anna Maria Scattolin, Piera Viero, Rosaria Sancetta, Anna Pascarella, Michele Vespignani, Renato Bassan
    e2015001
    2015-01-01
    https://doi.org/10.4084/mjhid.2015.001
    2332
    PDF: 1343
    HTML: 17102
    Bassan Fig.1: 151
    Bassan Fig.2: 162
    Bassan Fig.4: 143
    Fig.3: 208
  • LIGHT CHAIN AMYLOIDOSIS

    Paolo Milani, Giampaolo Merlini, Giovanni Palladini
    e2018022
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.022
    5902
    PDF: 2354
    HTML: 1339
  • Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India

    Mary Theresa Sylvia, Biswajit Dey, Debdatta Basu, Sajini Elizabeth Jacob, Rakhee Kar, Biswajit Dubashi
    e2016060
    2016-11-01
    https://doi.org/10.4084/mjhid.2016.060
    3246
    PDF: 792
    HTML: 2973
    Figure 1a and 1b: 155
    Figure 2: 164
    Figure 3: 182
    Figure 4: 167
    Figure 5: 168
    Tables 1-5: 156
  • HOW I TREAT FEBRILE NEUTROPENIA

    Marcio Nucci
    e2021025
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.025
    6903
    PDF: 3971
    HTML: 446
  • Intracardiac thrombosis in the three-year-old boy with normal left ventricle systolic function in MIS-C associated with COVID-19

    Stasa Krasic, Sasa Popovic, Ruzica Kravljanac, Sergej Prijic, Vladislav Vukomanovic
    e2022028
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.028
    885
    PDF: 463
    HTML: 267
  • PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.

    Anil Pathare, Salam Alkindi, prof.
    e2019058
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.058
    1677
    PDF: 1017
    HTML: 371
  • ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

    Mohamed L. Sorror, Rainer F. Storb
    e2010015
    2010-06-08
    https://doi.org/10.4084/mjhid.2010.015
    1024
    PDF: 644
    HTML: 2235
  • ACTIVIN RECEPTOR LIGAND FOR THR TREATMENT OF BETA-THALASSEMIA: a SERENDIPITOUS DISCOVERY

    Irene Motta, Valentina Brancaleoni, Isabella Nava, Paola Delbini, Lorena Duca
    e2020075
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.075
    1589
    PDF: 1430
    HTML: 523
  • SPECTRUM AND IMMUNOPHENOTYPIC PROFILE OF ACUTE LEUKEMIA: A TERTIARY CENTER FLOW CYTOMETRY EXPERIENCE

    Nishit Gupta, Ravikiran Pawar, Sambhunath Banerjee, Subhajit Brahma, Asish Rath, Sundar Shewale, Mayur Parihar, Manish Singh, Arun SR, Shekhar Krishnan, Arpita Bhattacharyya, Anirban Das, Jeevan Kumar, Saurabh Bhave, Vivek Radhakrishnan, Reena nair, Mammen Chandy, Neeraj Arora, Deepak Kumar Mishra
    e2019017
    2019-02-26
    https://doi.org/10.4084/mjhid.2019.017
    3286
    PDF: 1649
    HTML: 440
  • IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/µL?

    Benedetto Maurizio Celesia, Dr., Andrea Marino, Dr., Rosa Fontana del Vecchio, Dr., Roberto Bruno, Dr., Filippo Palermo, Professor, Maria Gussio, Dr., Giuseppe Nunnari, Professor, Bruno Cacopardo, Professor
    e2019063
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.063
    1479
    PDF: 765
    HTML: 224
  • Community-acquired Carbapenem-resistant Escherichia coli Bacteremia Complicated by c: A Case Report

    Yu Chen, Jin Zhang, wenqiang kong
    e2026005
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.005
    581
    PDF: 467
    HTML: 99
  • JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia

    Phakatip Sinlapamongkolkul, Pacharapan Surapolchai, Vip Viprakasit
    e2023056
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.056
    2395
    PDF: 624
    Suppl. Files: 287
    HTML: 178
  • IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES

    seval ozen, alper Dai, enes coskun, serdar oztuzcu, sercan ergun, elif aktekin, sibel yavuz, Ali Bay
    e2014067
    2014-10-28
    https://doi.org/10.4084/mjhid.2014.067
    1807
    PDF: 950
    HTML: 1115
    Untitled: 164
    Untitled: 183
    Untitled: 164
    Untitled: 170
  • IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME

    Rosangela Invernizzi, Federica Quaglia, Matteo Giovanni Della Porta
    e2015035
    2015-04-26
    https://doi.org/10.4084/mjhid.2015.035
    3398
    PDF: 2290
    HTML: 23369
    Untitled: 209
    Untitled: 222
    Untitled: 240
  • PATHOPHISIOLOGY OF SICKLE CELL DISEASE AND NEW DRUGS FOR THE TREATMENT

    Lucia De Franceschi
    e2009024
    2009-12-26
    1086
    PDF: 660
    HTML: 11084
  • I INCREASED RISK OF LYMPHOMA IN MEN INFECTED WITH TUBERCULOSIS

    guangliang Chen
    e2021053
    2021-08-28
    https://doi.org/10.4084/MJHID.2021.053
    1184
    PDF: 492
    HTML: 330
  • GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA

    Pouyan Kheirkhah, Ana M. Avila-Rodriguez, Bartlomiej Radzik, Carlos Murga-Zamalloa
    e2021067
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.067
    1508
    PDF: 634
    HTML: 271
  • THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone

    George J Kontoghiorghes, Marios Kleanthous, Christina N. Kontoghiorghe
    e2020011
    2020-01-01
    https://doi.org/10.4084/mjhid.2020.011
    2462
    PDF: 1608
    HTML: 660
  • PATIENTS WITH HAEMOGLOBINOPATHIES AND CHRONIC HEPATITIS C: A REALLY DIFFICULT TO TREAT POPULATION IN 2016?

    Kalliopi Zachou, Pinelopi Arvaniti, Nikolaos K. Gatselis, Kalliopi Azariadis, Georgia Papadamou, Eirini Rigopoulou, George N. Dalekos
    e2017003
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.003
    2966
    PDF: 994
    HTML: 2067
    Cover letter: 185
  • CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.

    Vincenzo De Sanctis
    e2020006
    2020-01-01
    https://doi.org/10.4084/mjhid.2020.006
    4314
    PDF: 1536
    HTML: 460
  • AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS

    Giuseppe Visani, Paola Picardi, Patrizia Tosi, Alessandro Isidori
    e2012075
    2012-11-07
    https://doi.org/10.4084/mjhid.2012.075
    2615
    PDF: 882
    HTML: 2126
  • Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients

    NICOLA SGHERZA, Stefania Zucano, Angelantonio Vitucci, Antonio Palma, Francesco Tarantini, Daniela Campanale, Luigi Vimercati, Angela Maria Vittoria Larocca, Domenico Visceglie, Amalia Acquafredda, Angelo Ostuni, Daniela Di Gennaro, Carmen Vitucci, Silvio Tafuri, Pellegrino Musto
    e2022056
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.056
    1211
    HTML: 294
    PDF: 513
  • DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES

    Prof. Giuseppe Leone, Emiliano Fabiani, Maria Teresa Voso
    e2022030
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.030
    1419
    HTML: 480
    PDF: 841
  • MALARIA IN PREGNANCY

    Ebako Ndip Takem, Umberto D'Alessandro
    e2013010
    2013-01-02
    https://doi.org/10.4084/mjhid.2013.010
    4959
    PDF: 2172
    HTML: 7827
  • Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature

    Jayastu Senapati, Anup J Devasia, Abhijeet Ganapule, Leni George, Auro Viswabandya
    e2014016
    2014-02-17
    https://doi.org/10.4084/mjhid.2014.016
    2011
    PDF: 928
    HTML: 1771
    Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 170
  • HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN ADULTS: LOW INCIDENCE OF PRIMARY NEOPLASM AS A TRIGGER IN A CASE SERIES FROM TURKEY

    Ferhat Arslan
    e2018047
    2018-09-01
    https://doi.org/10.4084/mjhid.2018.047
    1610
    PDF: 917
    HTML: 229
    Figure 1: 181
  • CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab

    r. Salam Al-Kindi, Isra Al-Busaidi, Anil Pathare
    e2024046
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.046
    1351
    PDF: 1161
    HTML: 126
  • Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES

    Giuseppe Leone, Luigi Maria Larocca, Eligio Pizzigallo
    e2009001
    2009-06-22
    3360
    PDF: 588
    HTML: 675
151 - 200 of 200 items << < 1 2 3 4 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.